Skip to content

Management of Obstructive Sleep Apnea (OSA) in Children and Maxillary and Mandibular Development

Management of Obstructive Sleep Apnea (OSA) in Children and Maxillary and Mandibular Development

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03267927
Acronym
SAOS
Enrollment
4
Registered
2017-08-31
Start date
2017-11-05
Completion date
2019-03-25
Last updated
2020-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Keywords

OSA, Polysomnography, Rapid palatal expansion, Mandibular advancement, Sleep position

Brief summary

Assessment of the association of maxillary expansion using a rapid palatal expansion, use of a mandibular advancement appliance (MGA™) and of a device allowing sleep in a semi-seated position (Yoobreath™) in patients with Obstructive Sleep Apnea (OAS). MGA™ and YooBreath™ constitute the Yookid system™.

Detailed description

Obstructive Sleep Apnea syndrome (OSA) shows a 10% morbidity rate in children with a higher rate between the ages of 3 and 5. Generally speaking, its prevalence is underestimated. Furthermore, detecting OSA remains difficult due to its particular physiopathology. The decrease in nasopharyngeal airway dimensions is the most common etiology. This decrease is related to soft tissues as well as maxillomandibular abnormalities. The aim of the study is to show that reducing sleep apnea in children remains possible when inducing rapid palatal expansion and mandibular advancement using the Yookid™ system. The Yookid™ system associates a mandibular advancement appliance and repositioning of the patient during sleep.

Interventions

Fixation of rapid palatal expansion from day 0 to day 60

DEVICEMGA™ system

Use of a mandibular advancement Appliance during the night from day 60 to day 180 (end of treatment from day 120 if Angle Class I is obtained)

DEVICEYoobreath™ system

Use of a device allowing sleep in a semi-seated position during the night from day 15 to day 180 (end of treatment from day 120 if Angle Class I is obtained)

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* 5 to 7 year-old children * Children with American Society of Anesthesiologists score (ASA) of 1 and 2 * Children with signs of OSA during examination and clinical exam * Children with apnea-hypopnea index (AHI) from 1 to 5 (one to five sleep apnea / hour during PSG) * Children with a class II division 1 angle malocclusion (at the canines level rotation center) and skeletal class II according to Delaire analysis

Exclusion criteria

* OSA associated to syndromic disorder and/or syndrome * Body/Mass Index (BMI) \> 97ème percentile according to development curves (obese children) * Central sleep apnea * Respiratory allergy * Previous ear, nose and throat (ENT) surgery * Hypertrophic tonsils needing surgery * Adenoid hypertrophy needing surgery * Patients with ankyloglossia

Design outcomes

Primary

MeasureTime frame
Assessment in 5 to 7 year-old children the efficacy on OSA (removal or decrease of apnea/hypopnea) of Rapid Palatal Expansion combined with advancement using a mandibular advancement appliance (MGA™)Day 180
Assessment in 5 to 7 year-old children the efficacy on OSA (removal or decrease of apnea/hypopnea) of Rapid Palatal Expansion combined with a device allowing a semi-seated sleeping position (YooBreath™)Day 180

Secondary

MeasureTime frameDescription
Assessment of quality of wakefulnessDay 180Assessment of quality of wakefulness by a questionnaire
Measurement of lengthening of mandibular body and ramusDay -7, day 180Assessment of mandible development by an orthodontist using cephalometric analysis
Improvement of breathingDay -7, day 180Improvement of breathing defined by polysomnography
Assessment of dental occlusionDay -7, day 180Assessment of dental occlusion (clinical and using casts): diagnosis of Angle class
Assessement by the child and the parents of the treatment and the devices usedDay 180Assessement by the child and the parents of the treatment and the devices used by two questionnaires (one for parents and one for the child)
Assessment of intensity of pain during rapid palatal expansionDay 60Assessment of intensity of pain after fixing of rapid palatal expansion using a Visual Analogue Scale (VAS)
Assessment of duration of pain during rapid palatal expansionDay 60Number of painful days after fixing of rapid palatal expansion
Sleep improvementDay -7, day 180Measurement by polysomnography of desaturation index, micro arousal index and snoring index
Assessment of salivary disorders the morning on waking after using the MGA™ systemDay 60, day 90, day 120, day 150, day 180Assessment of salivary disorders the morning on waking by a questionnaire
Assessment of duration of dental pain the morning on waking after using the MGA™ systemDay 60, day 90, day 120, day 150, day 180Number of painful days at the mandible the morning on waking
Assessment of pain related to the semi-seated positionDay 15, day 60, day 90, day 120, day 150, day 180Assessment of pain related to the semi-seated position using a Visual Analogue Scale (VAS)
Assessment of disorders in falling asleep and sleep quality (micro arousals)Day 15, day 60, day 90, day 120, day 150, day 180Assessment of disorders in falling asleep and sleep quality (micro arousals) by a questionnaire
Assessment of risk of falling using the Yoobreath system™Day 15, day 60, day 90, day 120, day 150, day 180Number of falls
Assessment of the complianceDay 0, day 15, day 60, day 90, day 120, day 150, day 180Reporting of side effects
Assessment of intensity of dental pain the morning on waking after using the MGA™ systemDay 60, day 90, day 120, day 150, day 180Assessment of intensity of dental pain the morning on waking using a Visual Analogue Scale (VAS)
Assessment of quality of sleepDay 180Assessment of quality of sleep by a questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026